We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Leading Ultrasound Imaging Vendor Announces FDA 501(k) Clearance for New Visualization Solution

By HospiMedica International staff writers
Posted on 07 Dec 2015
A company specializing in designing innovative ultrasound tools, and point-of-care visualization, announced it has received US Food and Drug Administration (FDA) 510(k) clearance for its newest medical visualization solution, intended to meet the needs of mobile clinicians.

Clinicians often rely on mobile ultrasound systems for point-of-care diagnosis of patients. More...
The new solution enables clinicians to store exam findings, submit reports, and access learning resources and patient information. The system also connects with remote providers to provide near real-time assessment. This makes the system suitable for use in the field and in telemedicine.

The iViz solution was developed by FUJIFILM SonoSite (Bothell, WA, USA), a world leader in bedside and point-of-care ultrasound solutions, and ultra-high frequency micro-ultrasound technology. The iViz is a next generation architecture and platform that integrates ultrasound systems with supporting medical IT systems. The iViz is the first medical visualization solution that has bidirectional Electronic Medical Record (EMR) connectivity through the FUJIFILM Synapse Vendor Neutral Archive (VNA). The iViz automatically takes patient demographics from the EMR saving clinicians’ time and effort, and can send patient reports to the EMR. The iViz is based on the Android Operating System (OS) and includes web-browsing, email and ECG capabilities. The system is light-weight, and features a high-resolution, seven-inch display touchscreen, a wide dynamic range, and color flow images, and multiple imaging modes and exams to meet the needs of different medical providers.

Masayuki Higuchi, president and CEO, FUJIFILM SonoSite, said, “iViz is a revolutionary solution for clinicians and represents a landmark in FUJIFILM SonoSite’s innovation. It achieves new levels of image performance and provides unprecedented connectivity in a highly mobile platform. Through iViz, we expand our core mission of increasing access to ultrasound to improve patient care quality and reduce healthcare costs."

Related Links:

FUJIFILM SonoSite
iViz Video



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Spirometry & Oximetry Software
MIR Spiro
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.